期刊文献+

Schwartz-Jampel综合征四例分析 被引量:3

Clinical analysis of four patients with Schwartz-Jampel syndrome
原文传递
导出
摘要 目的 探讨Schwartz-Jampel综合征的临床特征、诊断和治疗.方法 对4例SchwartzJampel综合征患儿的临床资料进行分析.结果 4例均为男性,起病年龄6个月至1岁3个月,平均10个月,均为隐匿起病,就诊年龄2岁2个月至10岁,平均5岁11个月.身高位于同年龄同性别儿童第3百分位数值以下,面部表情僵硬、口唇前撅、张口困难,睑裂狭小、四肢僵硬.辅助检查:肌酸激酶229 ~1039 U/L(正常值<200 U/L),肌酸激酶同工酶30 ~ 45 U/L(正常值<25 U/L),乳酸脱氢酶455 ~716 U/L(正常值<240 U/L).肌电图可见强直电位,影像学可见骨骼畸形,2例患儿肌肉活组织病理检查提示Ⅰ型肌纤维大小不规则,比例失调.4例患儿均予口服B族维生素对症治疗及康复训练,给予其中1例卡马西平口服,四肢肌肉僵硬及睑肌痉挛均有好转.结论 Schwartz-Jampel综合征以特殊面容、骨骼畸形、肌强直、身材矮小为主要临床表现,血清肌酶升高,肌电图强直电位.部分患儿卡马西平治疗有效. Objective To analyze the clinical manifestation,diagnosis and treatment of SchwartzJampel syndrome (SJS).Method The clinical data,including demographic,laboratory tests (creatase,creatine kinase,etc.) and electromyography of 4 children with SJS were analyzed.Result All the 4patients were male.The age of onset was from 0.5 to 1.25 years ( average 0.83 years).The onset of 4patients was insidious,the age to see doctor was from 2.17 to 10 years (average 5.92 years),body height was less than the third percentile rank in the children of same age and gender,they presented with facial expression stiffness,microstomia,difficult in opening mouth,blepharophimosis,limbs stiffness and,so formed a characteristic phenotype.Investigations showed the creatase in serum increased,creatine kinase (CK):229 - 1039 U/L( normal value 〈 200 U/L),Creatine Kinase MB (CK-MB):30 - 45 U/L( normal value 〈25 U/L),lactate dehydrogenase (LDH):455 -716 U/L (normal value 〈 240 U/L).General myotonia potential was found in electromyography,osteoarticular deformities in medical imaging,and muscle biopsy in 2 patients showed type Ⅰ muscle fibers differed in size and were disproportionate.All the patients took oral vitamine B,and received rehabilitation training,1 patient took carbamazepine for 1 month,blepharophimosis and limbs stiffness was improved.Conclusion SJS is a rare autosomal recessive inherited disease.Clinical manifestations of SJS are characteristic facies,skeletal abnormalities,generous myotonia and short stature.Carbamazepine is effective for treatment.
出处 《中华儿科杂志》 CAS CSCD 北大核心 2012年第3期231-234,共4页 Chinese Journal of Pediatrics
关键词 骨软骨发育不良 肌强直 Schwartz-Jampel综合征 Schwartz-Jampel syndrome Osteochondrodysplasias Myotonia
  • 相关文献

参考文献16

  • 1Schwartz O,Jampel RS.Congenital blepharophimosis associated with a unique generalized myopathy.Arch Ophthalmol,1962,68:52-57.
  • 2Singh B,Biary N,Jamil AA,et al.Schwartz-Jampel syndrome:evidence of central nervous system dysfunction.J Child Neurol,1997,12:214-217.
  • 3郑日亮,栾兴华,陈彬,吕鹤,王朝霞,袁云.Schwartz-Jampel综合征一例[J].中华神经科杂志,2008,41(3):215-215. 被引量:4
  • 4闫欣,胡洪涛,马志刚,闫立荣.Schwartz-Jampel综合征临床特点分析(附首组国人家族同胞病例报告并文献复习)[J].中风与神经疾病杂志,2010,27(10):909-913. 被引量:3
  • 5Nicole S, Ben HC,Beighton P,et al. Localization of the Schwartz-Jampel syndrome (SJS) locus to chromosome 1 p34-p36.1 by homozygosity mapping. Hum Mol Genet,1995,4:1633-1636.
  • 6Arikawa-Hirasawa E,Le AH,Nishino I,et al. Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome,with myotonic myopathy and chondrodysplasia.Am J Hum Genet,2002,70:1368-1375.
  • 7Nicole S,Davoine CS,Topaloglu H,et al.Perlecan,the major proteoglycan of basement membranes,is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet,2000,26:480-483.
  • 86th Congress of the International Child Neurology Association.1 st Iberoamerican Congress of Pediatric Neurology. Buenos Aires,Argentina, November 8-13, 1992.Abstracts.Pediatr Neurol,1992,8:344-411.
  • 9Natwar S,Venkataraman V,Kalpana G.A case of SchwartzJampel syndrome.J Pediatr Neurol,2006,4:135-137.
  • 10Samimi SS,Lesley WS.Craniocervical CT and MR imaging of Schwartz-Jampel syndrome.AJNR Am J Neuroradiol,2003,24:1694-1696.

二级参考文献32

  • 1Regalo SC, Vitti M, Semprini M, et al. The effect of the Schwartz-Jampel syndrome on masticator and facial musculatures-an electromyographic analysis. Electromyogr Clin Neurophysiol, 2005,45 : 183-189.
  • 2Ho NC, Sandusky S, Madike V, et al. Clinico-pathogenetic findings and management of chondrodystrophic myotonia ( Schwarlz-Jampel syndrome ): a case report. BMC Neurol, 2003, 3: 3.
  • 3Fariello R, Meloff K, Murphy EG, et al. A case of Schwarlz-Jampel syndrome with unusual muscle biopsy findings. Ann Neurol, 1978, 3: 93-96.
  • 4A. Giedion,E. Boltshauser,J. Briner,G. Eich,G. Exner,H. Fendel,L. Kaufmann,B. Steinmann,J. Spranger,A. Superti-Furga.Heterogeneity in Schwartz-Jampel chondrodystrophic myotonia[J]. European Journal of Pediatrics . 1997 (3)
  • 5Milachowski,Keyl,Witt.Schwartz-Jampel syndrome.Orthopedic and neurological problems of chondrodystrophic myotonia. Z Or-thop Ihre Grenzgeb . 1982
  • 6Samimi SS,Lesley WS.Craniocervical CTand MR Imaging of Schw-artz-Jampel Syndrome. American Journal of Neuroradiology . 2003
  • 7Gazali M,Varghese E,Varady Fet al.Neonatal Schwartz-Jampel syndrome:a common autosomal recessive syndrome in the United Arab Emirates. Journal of Medical Genetics . 1996
  • 8Nicole S,Topaloglu H,Fontaine B.102nd ENMC International Work-shop on Schwartz-Jampel Syndrome. Neuromuscular Disorders . 2003
  • 9Nicole S,Ben Hamida C,Beighton Pet al.Localization of the Schw-artz-Jampel syndrome (SJS)locus to chromosome1p34-p36.1by ho-mozygosity mapping. Human Molecular Genetics . 1995
  • 10Vargel IG,Canter HI,Topaloglu Het al.Results of botilinum toxin:An application to blepharospasm in schwartz-jampel syndrome. J Cranifac Surg . 2006

共引文献3

同被引文献28

  • 1谢娟娟,沈南平.Schwart-Jampel综合征1例[J].中国实用儿科杂志,2004,19(7):419-419. 被引量:1
  • 2Schwartz 0,Jampel R. Congenital blepharophimosis associated with a unique generalized myopathy[J]. Arch Ophthalmol, 1962 , 68 (1 ) :52-57.
  • 3Iwata S, Itoa M, Nakata T, et al. A missense mutation in domain III in HSPG2 in Schwartz-lampelsyndrome compromises secretion of perlecan into the extracellular space[J]. Neuromuscul Disord, 2015, 25 (8) :667 -671.
  • 4Di Rocco M, Stella G, Bruno C, et al. Long-term survival in StuveWiedemann syndrome: a neuro-myo-skeletal disorder with manifestations of dysautonomia[J]. AmJ Med Genet A, 2003, 118( 4) :362-368.
  • 5Sturn M, Davoine CS, Vicart S, et al' Spectrum of HSPG2 ( Perlecan) mutations in patients with Schwartz-Jampel syndrome[J]. Hum Mutat,2006 ,27( 11) : 1082-1091.
  • 6Rodgers KD, Sasaki T, Aszodi A, et al. Reduced perlecan in miceresults in chondrodysplasia resembling Schwartz-Jampel syndrome[J]. Hum Mol Genet ,2007 ,16(5) :515,528.
  • 7Giedion A, Boltshauser E, BrinerJ. et al. Heterogeneity in Schwartz-Jampel chondrodystrophic myotonia] J]. EuropJ Pediat, 1997,27(5): 214-223.
  • 8Aryaa R, Sharmaa S, Gupta N. SchwartzJampel syndrome in children[J].J Clin Neurosci, 2013,20(2) :313-317.
  • 9AI-Gazali LI, Varghese M, Varady E, et al. Neonatal SchwartzJampel syndrome: acommon autosomal recessive syndrome in the United Arab Emirates[J].J Med Genet, 1996,33(3) :203-211.
  • 10Sreekanth K, Cynthia K, Nigel M. Schwartz-Jampel syndrome: a review of the literature and case report[J]. Spec Care Dentist, 2012,32(3) :105-111.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部